5-FU+LV+BeviFOLFOXIRI+BevŒγˆΫŽ—Γ–@j
€–Ϊ–Ό Šξ€—Κ ’PˆΚ }ަ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 @ @ @ @ @ @ @ @ @ @ @ @ @ @
‘S‘ΜƒXƒPƒWƒ…[ƒ‹ œ ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x ‹x @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒAƒoƒXƒ`ƒ“ 5 mg/‡s š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒŒƒ{ƒzƒŠƒi[ƒg 200 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
ƒtƒ‹ƒIƒƒEƒ‰ƒVƒ‹ 3200 mg/‡u š @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
@ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @ @
y’ˆΣƒ`ƒ…ƒEƒCŽ–€ƒWƒRƒEz
FOLFOXIRI+Bev‚π12ƒR[ƒXŽ{sƒVƒRƒEŒγƒSˆΫŽ—Γ–@ƒCƒWƒŠƒ‡ƒEƒzƒE‚ΦˆΪsƒCƒRƒE